Key result
Infants diagnosed with hypertrophic cardiomyopathy before 1 year of age had a significantly higher risk of syncope compared to those diagnosed later in childhood (OR 15, p=0.02).
Why the study?
Does age of diagnosis (infancy vs >1 year of age) affect the clinical and echocardiographic presentation of pediatric patients with hypertrophic cardiomyopathy?
Observational (n=39)
No
Does age of diagnosis (infancy vs >1 year of age) affect the clinical and echocardiographic presentation of pediatric patients with hypertrophic cardiomyopathy?
Odds Ratio: 15 (95% CI 0.7473–301.1)
Absolute Event Rate: 23.5% vs 0%
p-value: p=0.02
Hypertrophic cardiomyopathy presenting in infancy is associated with more severe clinical and echocardiographic features, including higher rates of syncope, asymmetric septal hypertrophy, and diastolic impairment, compared to presentation later in childhood.
May warrant closer syncope surveillance in infant-diagnosed HCM; leaves open whether early onset independently predicts risk in larger cohorts.
Background : Hypertrophic cardiomyopathy is a rather common hereditary disease with an autozomal dominant character, caused by mutations of genes that code for proteins of the cardiac sarcomere. The observed prevalence of this disease is much lower in pediatric patients compared to adults, because it’s late gene expression. Hypertrophic cardiomyopathy presenting in infancy has been shown to have a very high mortality. Methods : Thirty-nine patients diagnosed with hypertrophic cardiomyopathy in the III rd Pediatric Cardiology Department from Tîrgu Mureş were included in this study. Patients were divided into two groups: group 1 – patients diagnosed during infancy, group 2 – patients diagnosed after 1 year of age. Data regarding familial and personal history, and echocardiographic findings were compared between these two groups. Results : Group 1 included 17 patients and group 2 - 22 patients. Positive familial history was found in both groups (group 1 – 6 cases, group 2 – 3 cases), all of them in obstructive forms. Syncope was found in four cases, all of them in group 1 (p=0.02; odds ratio 15; 95% CI, 0.7473 to 301.1). While in group 1, asymmetric septal hypertrophy was predominant (64.7%), in group 2 – concentric left ventricular hypertrophy predominated (54.5%). Obstructive hypertrophic cardiomyopathy was found in 14 patients in group 1 (82.4%) compared to 13 patients in group 2 (59.1%). Diastolic function was impaired more predominantly in group 1 (p=0.0274; odds ratio 11.67; 95% CI, 1.526 to 89.17). Conclusions : hypertrophic cardiomyopathy has an extensive clinical variability with regard to age of onset, severity and progression of disease.
No takes yet. Share an insight, caveat, or question.
Blesneac et al. (2015) conducted an observational in Hypertrophic cardiomyopathy (n=39). Diagnosis of HCM during infancy (<1 year of age) vs. Diagnosis of HCM after 1 year of age was evaluated on Syncope (OR 15, 95% CI 0.7473-301.1, p=0.02). Infants diagnosed with hypertrophic cardiomyopathy before 1 year of age had a significantly higher risk of syncope compared to those diagnosed later in childhood (OR 15, p=0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: